R(+)-methanandamide-induced cyclooxygenase-2 expression in H4 human neuroglioma cells:: possible involvement of membrane lipid rafts

被引:29
作者
Hinz, B [1 ]
Ramer, R [1 ]
Eichele, K [1 ]
Weinzierl, U [1 ]
Brune, K [1 ]
机构
[1] Univ Erlangen Nurnberg, Dept Expt & Clin Pharmacol & Toxicol, D-91054 Erlangen, Germany
关键词
cannabinoids; R(+)-methanandamide; non-cannabinoid receptor-mediated effects; membrane lipid rafts; cyclooxygenase-2; human neuroglioma cells; mitogen-activated protein kinases;
D O I
10.1016/j.bbrc.2004.09.095
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Cannabinoids induce the expression of the cyclooxygenase-2 (COX-2) isoenzyme in H4 human neuroglioma cells via a pathway independent of cannabinoid- or vanilloid receptor activation. The underlying mechanism was recently shown to involve increased synthesis of ceramide. which in turn leads to activation of p38 and p42/44 mitogen-activated protein kinases (MAPKs). The present study investigates a possible contribution of membrane lipid rafts to cannabinoid-induced COX-2 expression. To address this issue, we tested the influence of methyl-beta-cyclodextrin (MCD), a membrane cholesterol depletor, on COX-2 expression by the endocannabinoid analogue R(+)-methanandamide (R(+)-MA). Incubation of H4 cells with MCD was associated with a loss of lipid raft integrity and a substantial inhibition of R(+)-MA-induced COX-2 expression and subsequent formation of prostaglandin E over, MCD was shown to suppress signal transduction steps upstream to COX-2 induction by R(+)-MA. Accordingly, the cholesterol depletor suppressed R(+)-MA-induced formation of ceramide as well as phosphorylation of p38 and p42/44 MAPKs. Together. our results sua-est that R(+)-MA induces COX-2 expression in human neuroglioma cells via a pathway linked to lipid raft microdomains. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:621 / 626
页数:6
相关论文
共 45 条
[1]  
Alonso MA, 2001, J CELL SCI, V114, P3957
[2]   Cannabinoid-receptor-independent cell signalling by N-acylethanolamines [J].
Berdyshev, EV ;
Schmid, PC ;
Krebsbach, RJ ;
Hillard, CJ ;
Huang, CS ;
Chen, NY ;
Dong, ZG ;
Schmid, HHO .
BIOCHEMICAL JOURNAL, 2001, 360 (360) :67-75
[3]   Membrane lipid microdomains and the role of PKCθ in T cell activation [J].
Bi, K ;
Altman, A .
SEMINARS IN IMMUNOLOGY, 2001, 13 (02) :139-146
[4]   Membrane cholesterol but not putative receptors mediates anandamide-induced hepatocyte apoptosis [J].
Biswas, KK ;
Sarker, KP ;
Abeyama, K ;
Kawahara, K ;
Iino, S ;
Otsubo, Y ;
Saigo, K ;
Izumi, H ;
Hashiguchi, T ;
Yamakuchi, M ;
Yamaji, K ;
Endo, R ;
Suzuki, K ;
Imaizumi, H ;
Maruyama, I .
HEPATOLOGY, 2003, 38 (05) :1167-1177
[5]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[6]   ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASES BY STIMULATION OF THE CENTRAL CANNABINOID RECEPTOR CB1 [J].
BOUABOULA, M ;
POINOTCHAZEL, C ;
BOURRIE, B ;
CANAT, X ;
CALANDRA, B ;
RINALDICARMONA, M ;
LEFUR, G ;
CASELLAS, P .
BIOCHEMICAL JOURNAL, 1995, 312 :637-641
[7]  
Christian AE, 1997, J LIPID RES, V38, P2264
[8]  
DEADWYLER SA, 1995, J PHARMACOL EXP THER, V273, P734
[9]   The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines [J].
Derocq, JM ;
Bouaboula, M ;
Marchand, J ;
Rinaldi-Carmona, M ;
Ségui, M ;
Casellas, P .
FEBS LETTERS, 1998, 425 (03) :419-425
[10]  
FELDER CC, 1992, MOL PHARMACOL, V42, P838